Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Oxymetazoline hydrochloride

EU orphan designation number: EU/3/17/1892   
Active ingredient: Oxymetazoline hydrochloride
Indication: Treatment of spinal cord injury
Sponsor: RDD Pharma Limited
Norfolk House, 4 Station Road, Saint Ives PE27 5AF, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/07/2017 Orphan designation EMA/OD/325/16 (2017)5156 of 17/07/2017